neumonia severa
DESCRIPTION
NAC severaTRANSCRIPT
![Page 1: Neumonia Severa](https://reader036.vdocuments.pub/reader036/viewer/2022082513/55761a47d8b42a4e1c8b4763/html5/thumbnails/1.jpg)
NAC Severa
![Page 2: Neumonia Severa](https://reader036.vdocuments.pub/reader036/viewer/2022082513/55761a47d8b42a4e1c8b4763/html5/thumbnails/2.jpg)
Alta mortalidad hasta 56%
Relación carga MO;virulencia;F. Huesped.
![Page 3: Neumonia Severa](https://reader036.vdocuments.pub/reader036/viewer/2022082513/55761a47d8b42a4e1c8b4763/html5/thumbnails/3.jpg)
![Page 4: Neumonia Severa](https://reader036.vdocuments.pub/reader036/viewer/2022082513/55761a47d8b42a4e1c8b4763/html5/thumbnails/4.jpg)
![Page 5: Neumonia Severa](https://reader036.vdocuments.pub/reader036/viewer/2022082513/55761a47d8b42a4e1c8b4763/html5/thumbnails/5.jpg)
Resistencia S. Pneumoniae PNC 15% (USA) Macrolidos 30% Fluoroquinolonas 1%
S. Aureus Meticilinresistente 0,5-0,6 casos por 100.000 hbt
Influenza (h1N1) 2009 19% Mortalidad.
Diagnóstico Clinico-Radiologico más Pruebas de Dg MO
Clinica Tos (41%) – Fiebre (28%)
Radiologico Consolidación Lobar o Multilobar; Infiltracion Intersticial; Cavitaciones.
Pruebas dg PCR ; PCT
MO ATS 2007 recomienda Tests para buscar etiologia.
![Page 6: Neumonia Severa](https://reader036.vdocuments.pub/reader036/viewer/2022082513/55761a47d8b42a4e1c8b4763/html5/thumbnails/6.jpg)
Score PSI/CURB-65
Aun no validados SMART COP/ PIRO
Tratamiento Empirico:
![Page 7: Neumonia Severa](https://reader036.vdocuments.pub/reader036/viewer/2022082513/55761a47d8b42a4e1c8b4763/html5/thumbnails/7.jpg)
Inicio Terapia dentro 4 hrs Disminuye Mortalidad.
Switch oral HDN y clinica estable.
Duración Depende Factores.
No respuesta Buscar Causa/ descartar resistencia terapia/ descartar complicaciones
![Page 8: Neumonia Severa](https://reader036.vdocuments.pub/reader036/viewer/2022082513/55761a47d8b42a4e1c8b4763/html5/thumbnails/8.jpg)